‘We hope bilateral pharmaceutical trade between the US and India will grow at or above 10 per cent’

Read more

‘We are estimating revenue of Rs 75 crores in 2016’

Read more

India remains on USTR Priority Watch List

Read more

Pharmexcil organises series of initiatives during CPhI Japan

Read more

Wockhardt recalls 12 drugs in US made at two India units

Read more

US FDA public meeting on June 15 on reauthorisation of GDUFA

Read more

NPPA threatens action against companies yet to register in IPDMS

Read more

US FDA nod for generics of Abilify

Read more

Rusan Pharma launches first ‘Made in India’ NRT patch 2baconil

Read more

CPhI to conduct 3rd Annual Pharma Project Management Conference

Read more